Status
Conditions
Treatments
About
Open-label, non-randomized, prospective, multi-center, self-controlled clinical study with masked evaluation.
Full description
Eligible patients will receive 3 treatments (4-6 weeks apart) on the facial acne scars using Sofwave System.
Treatment may be administered after the enrollment and screening at the first visit, or it may occur later following the enrollment and screening activities based on site scheduling availabilities.
All patients will return to the clinic for one follow up visit at 3 months ± 3 weeks post last treatment (FU1). Methodology described in the protocol to evaluate efficacy and safety of treatments will be carried out at each visit at the clinic.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
60 participants in 1 patient group
Loading...
Central trial contact
Shlomit Mann, MSc; Ruthie Amir, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal